Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8490112rdf:typepubmed:Citationlld:pubmed
pubmed-article:8490112lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C0025598lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C0039225lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C0005508lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C0008562lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:8490112lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:8490112pubmed:issue3lld:pubmed
pubmed-article:8490112pubmed:dateCreated1993-6-17lld:pubmed
pubmed-article:8490112pubmed:abstractTextTwenty-four young healthy volunteers received a single dose of metformin 500 mg (Glucophage, Nordic Laboratories, Canada) in tablet form. Plasma concentrations were determined by HPLC in samples collected prior to and 0.33, 0.66, 1, 1.33, 1.66, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12, 15, 18, 24, and 30 h after dosing. Mean (+/- SD) Cmax was 682.1 (160.6) ng ml-1 at a mean (+/- SD) tmax of 2.4 (0.93) h. Overall elimination was monoexponential with a mean (+/- SD) half-life of 3.16 (0.47) h. We conclude that metformin is rapidly absorbed from this formulation and is also rapidly eliminated. Extrapolation to steady state predicts that equilibrium will be reached within 24 h.lld:pubmed
pubmed-article:8490112pubmed:languageenglld:pubmed
pubmed-article:8490112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490112pubmed:citationSubsetIMlld:pubmed
pubmed-article:8490112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490112pubmed:statusMEDLINElld:pubmed
pubmed-article:8490112pubmed:monthAprlld:pubmed
pubmed-article:8490112pubmed:issn0142-2782lld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:RaymondMMlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:CailléGGlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:LacasseYYlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:PerrottiEElld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:SpénardJJlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:ThiffaultJJlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:LandriaultHHlld:pubmed
pubmed-article:8490112pubmed:authorpubmed-author:PicirilliGGlld:pubmed
pubmed-article:8490112pubmed:issnTypePrintlld:pubmed
pubmed-article:8490112pubmed:volume14lld:pubmed
pubmed-article:8490112pubmed:ownerNLMlld:pubmed
pubmed-article:8490112pubmed:authorsCompleteYlld:pubmed
pubmed-article:8490112pubmed:pagination257-63lld:pubmed
pubmed-article:8490112pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:meshHeadingpubmed-meshheading:8490112-...lld:pubmed
pubmed-article:8490112pubmed:year1993lld:pubmed
pubmed-article:8490112pubmed:articleTitleBioavailability of metformin in tablet form using a new high pressure liquid chromatography assay method.lld:pubmed
pubmed-article:8490112pubmed:affiliationDepartment of Pharmacology, Université de Montréal, Canada.lld:pubmed
pubmed-article:8490112pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490112lld:pubmed